SELECTQUOTE ALERT: Bragar Eagel & Squire, P.C. is Investigating SelectQuote, Inc. on Behalf of SelectQuote Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) on behalf of SelectQuote stockholders. Our investigation concerns whether SelectQuote has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

On February 7, 2022, SelectQuote reported its financial results for the second quarter of fiscal year 2022. Among other items, SelectQuote reported a quarterly loss of $0.84 per share and a 45% year-over-year revenue decline. The Company's Chief Executive Officer Tim Danker attributed the shortfall to “unexpected challenges” in SelectQuote’s Medicare Advantage business. In addition, SelectQuote updated its 2022 guidance to forecast a net loss of $255 million to $236 million.

On this news, SelectQuote’s stock price fell $2.99 per share, or 45.79%, to close at $3.54 per share on February 8, 2022.

If you purchased or otherwise acquired SelectQuote shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Alexandra Raymond by email at [e-mail], telephone at [phone], or by filling out this contact form. There is no cost or obligation to you.